ORIGINAL ARTICLE

A systematic review of outcome measures reported for the therapeutic effectiveness of oral anticoagulation

D A Fitzmaurice¹, P Kesteven², K M Gee¹, E T Murray¹, R McManus¹

¹ Department of Primary Care and General Practice, The Medical School, University of Birmingham B15 2TT, UK
² Department of Haematology, The Freeman Hospital, High Heaton, Newcastle upon Tyne, NE7 7DN, UK

Correspondence to:
Correspondence to:
Dr D Fitzmaurice, Department of Primary Care and General Practice, The Medical School, University of Birmingham B15 2TT, UK;
d.a.fitzmaurice{at}bham.ac.uk

Aims: To evaluate the evidence of therapeutic international normalised ratio (INR) control reporting and to provide recommendations for future reporting, particularly for research and audit purposes.

Methods: A systematic review of literature published over a five year period describing therapeutic INR control. Papers were identified from the Medline electronic database, and those that met the quality criteria were reviewed independently by an academic general practitioner and a consultant haematologist.

Results: Fifteen papers were identified that met the quality criteria for review. The sample size of studies ranged from 53 to 2545 (mean, 483.9) patients. Follow up ranged from three months to 13 years. Twelve studies reported results from secondary care only, one from primary care only, and two from both primary and secondary care. Seven of the 15 papers reported percentage time in range, five of 15 papers reported mean INR, six of 15 papers reported the proportion of tests in range, and five of 15 papers reported mean warfarin dose. Additional methods of presenting INR results were: dose changes each month, distribution of INR results, deviation of INR value from mean, percentage dose changes, time between visits, and median INR value. Six papers reported only one outcome measure, six reported two outcomes, two papers reported three outcomes, and one paper reported five outcomes.

Conclusions: It is recommended that at least two outcome measures should be reported and measures should be selected so that both the INR determinations and dosing advice are monitored.

Keywords: warfarin; INR control; systematic review

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Alsheikh-Ali, A. A., Estes, N.A. M. III (2008). Anticoagulation Control in Atrial Fibrillation: Optimizing Risks and Benefits. Circ Cardiovasc Qual Outcomes 1: 72-73 [Full Text]  
• Wan, Y., Heneghan, C., Perera, R., Roberts, N., Hollowell, J., Glasziou, P., Bankhead, C., Xu, Y. (2008). Anticoagulation Control and Prediction of Adverse Events in Patients With Atrial Fibrillation: A Systematic Review. Circ Cardiovasc Qual Outcomes 1: 84-91 [Abstract] [Full Text]  
• Ansell, J., Hirsh, J., Hylek, E., Jacobson, A., Crowther, M., Palareti, G. (2008). Pharmacology and Management of the Vitamin K Antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133: 160S-198S [Abstract] [Full Text]  
• Greenblatt, D. J., von Moltke, L. L. (2005). Interaction of Warfarin With Drugs, Natural Substances, and Foods. J Clin Pharmacol 45: 127-132 [Abstract] [Full Text]  
• Fitzmaurice, D. A. (2004). Anticoagulation. CMAJ 170: 447-450 [Full Text]